Werner Cautreels
CIK 1237419 · View on SEC EDGAR ↗
First SEC filing: June 21, 2016 · Latest: June 21, 2016
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 29, 2024 | TRAW | P | 96,348 | — | — | 96,348 Direct | — | Acquired | (price as of 2026-08-20) |
| Dec. 29, 2024 | TRAW | P | 96,348 | — | — | 96,348 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 9, 2026 | TRAW | Stock Option (right to buy) | Common Stock (14,150) | $0.68 | July 9, 2036 | 14,150 | Acquired |
| March 8, 2026 | TRAW | Stock Option (right to buy) | Common Stock (31,258) | $1.60 | March 8, 2036 | 31,258 | Acquired |
| Dec. 12, 2025 | TRAW | Stock Option (right to purchase) | Common Stock (19,496) | $2.33 | Dec. 12, 2035 | 19,496 | Acquired |
| Oct. 12, 2025 | TRAW | Stock Option (right to purchase) | Common Stock (11,530) | $3.01 | Oct. 12, 2035 | 11,530 | Acquired |
| Dec. 29, 2024 | TRAW | Series A Warrant (right to buy) | Common Stock (96,348) | $13.42 | — | 96,348 | Acquired |
| Dec. 29, 2024 | TRAW | Pre-Funded Warrant (right to buy) | Common Stock (96,348) | $0.01 | — | 96,348 | Acquired |
| June 21, 2016 | RNAC | Stock Option (right to buy) | Common Stock (115,384) | $14.00 | June 20, 2026 | 115,384 | Acquired |
| June 25, 2015 | MCRB | Stock Option (right to buy) | Common Stock (15,000) | $18.00 | June 24, 2025 | 15,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 21, 2016 | RNAC | Common Stock | 301,203 | Direct |
| June 21, 2016 | RNAC | Employee Stock Option (right to buy)→ Common Stock (123,076) | 123,076 | Direct |
| June 21, 2016 | RNAC | Employee Stock Option (right to buy)→ Common Stock (57,692) | 57,692 | Direct |
| June 21, 2016 | RNAC | Employee Stock Option (right to buy)→ Common Stock (16,613) | 16,613 | Direct |
| June 21, 2016 | RNAC | Employee Stock Option (right to buy)→ Common Stock (41,025) | 41,025 | Direct |
| June 25, 2015 | MCRB | Stock Option (right to buy)→ Common Stock (100,000) | 100,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
TRAW
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $445,769 | — | $200,000 | — | — | — | $1,813 | $647,582 |
| 2023 | — | — | — | — | — | — | — | — |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $437,538 | — | — | $421,444 | $127,980 | — | $37,187 | $1,024,149 |
| 2017 | $460,000 | — | — | $1,386,733 | $145,000 | — | — | $1,991,733 |
| 2016 | $425,000 | — | — | $1,286,295 | $258,000 | — | — | $1,969,295 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.